America February 5, 2026
Eikon’s Upsized $381M IPO Ignites Nasdaq Debut
Oncology-focused biopharmaceutical firm Eikon Therapeutics stepped onto the public stage Thursday, as Eikon’s Upsized $381M IPO powered its Nasdaq debut…
America February 5, 2026
Oncology-focused biopharmaceutical firm Eikon Therapeutics stepped onto the public stage Thursday, as Eikon’s Upsized $381M IPO powered its Nasdaq debut…
By Rachel Moore
America February 4, 2026
Biotech company PrimeGen US will go public in the United States through a $1.5 billion business combination with blank-check firm…
By Rachel Moore
America October 27, 2025
In a bold move against a backdrop of federal uncertainty, MapLight Therapeutics has gone public, raising $251 million in its…
By Rihem Akkouche
America February 13, 2025
Aardvark Therapeutics Inc. made its public market debut Thursday, securing $94 million in its initial public offering (IPO). The obesity-focused…
By Rihem Akkouche